| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.39B | 88.07B | 88.78B | 81.78B | 72.11B | 57.60B |
| Gross Profit | 20.80B | 21.34B | 20.90B | 17.01B | 14.61B | 13.28B |
| EBITDA | 9.96B | 10.70B | 10.71B | 9.48B | 6.85B | 5.66B |
| Net Income | 5.57B | 5.92B | 5.72B | 5.15B | 2.95B | 1.97B |
Balance Sheet | ||||||
| Total Assets | 96.63B | 110.50B | 96.71B | 101.43B | 95.38B | 89.27B |
| Cash, Cash Equivalents and Short-Term Investments | 24.82B | 23.33B | 21.52B | 29.62B | 26.63B | 27.15B |
| Total Debt | 14.15B | 19.48B | 14.35B | 12.39B | 13.60B | 14.89B |
| Total Liabilities | 52.87B | 61.06B | 52.50B | 50.58B | 49.65B | 46.20B |
| Stockholders Equity | 43.70B | 49.38B | 44.15B | 50.79B | 45.68B | 43.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.26B | 3.03B | 2.05B | 1.28B | 6.43B |
| Operating Cash Flow | 0.00 | 9.11B | 9.35B | 4.67B | 4.49B | 7.87B |
| Investing Cash Flow | 0.00 | -13.52B | -6.51B | 450.66M | -3.08B | -1.30B |
| Financing Cash Flow | 0.00 | 3.52B | -10.80B | -2.10B | -1.98B | 84.35M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥73.11B | 12.40 | ― | 2.63% | 2.11% | 0.91% | |
74 Outperform | ¥20.37B | 24.83 | ― | 2.78% | 5.18% | 37.11% | |
70 Outperform | ¥75.03B | 8.80 | 11.47% | 1.88% | -0.81% | 28.73% | |
67 Neutral | ¥195.67B | 12.84 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.43B | 7.17 | ― | 3.09% | 7.43% | 47.68% | |
61 Neutral | ¥77.91B | 32.87 | ― | 0.55% | 2.93% | 10.00% |